AURO-BUSPIRONE

auro pharma inc🇨🇦 Health Canada

Approval Id: cc435407820d791b
Drug Approval Canada Name: AURO-BUSPIRONE
Product Name: AURO-BUSPIRONE
Status: Marketed
Status Date: 2020-10-30
Original Market Date: 2020-10-30
Din: 02500213
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:24.92
Atc Original: N05BE01 BUSPIRONE
Atc Name: n 05 be 01
Aig Number: 0116263001
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

BUSPIRONE HYDROCHLORIDE

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

cc435407820d791b

Type

Standard